Development of Potent Estrogen Receptor Beta Agonists for Treating Glioblastoma

The University of Texas at San Antonio

The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.

Principal Investigator(s)

McHardy Stanton

Funded by

Univ of TX HSC at San Antonio 745

Research Start Date

09/01/2022

Status

Active

Basic Research

Collaborative Project

Basic Research

Drug Discovery

Cancer

Bioscience Research Panel